Ann: Mesoblast Update on Chronic Low Back Pain Program, page-335

Responding to your speculation, IMO Dr Perin's ideas as expressed here mirror to a v. high degree those expressed by Dr Lightner (Cleveland Clinic) as mentioned in the interview which you quoted in your Post #: 56985676 i.e. at https://consultqd.clevelandclinic.org/the-state-of-play-of-stem-cells-in-inflammatory-bowel-disease/ , viz.

" (Interviewer) Why not choose one or the other track?

(Dr Lightner) That’s a good question. I think if you only do research, it becomes a challenge to see the unmet treatment needs, unless you have some strong collaborations with clinicians. And then on the clinical side, it’s very rewarding to treat a patient at a time. But I think as you see these problems that are affecting thousands of patients, it becomes a desire to be able to work on how can I treat things on a bigger scale or a larger level. So that’s why I like doing both. " (extract only)

The good ones like to keep their hands dirty. It's a grounding, and validating & humbling experience, all-in-one. And I believe it's why they took the oath in the first place.

PS: And @Wilba32, the specific URL on the THI site where Dr Perin talks about stem cell therapy for COVID-related HF conditions is:



(see, in particular from 7:55min. onward). This has probably been posted before, in which case, apologies.

Cheers all. Have a good one.